| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/29/2004 | WO2003068803A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147573 Metalloproteinase inhibitors |
| 07/29/2004 | US20040147571 Substituted oxazoles and thiazoles as hppar alpha agonists |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147553 Efficiency; side effect reduction; antiarthriutic agents; autoimmune diseases |
| 07/29/2004 | US20040147551 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147528 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147520 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 07/29/2004 | US20040147519 Sulfonylquinoxalone acetamide derivatives as bradykinin antagonists |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147506 Muscarinic acetylcholine receptor antagonist; Parkinson's disease; dystonia; analgesics; irritable bowel syndrome |
| 07/29/2004 | US20040147505 Neurodegradative diseases; antiinflammatory agents; analgesics; drug abuse |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147485 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 07/29/2004 | US20040147482 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation |
| 07/29/2004 | US20040147481 For the manufacture of a medicament for therapy of gastric acid-related diseases and gastro intestinal inflammatory diseases in animals and man, such as gastric ulcer, duodenal ulcer, reflex oesophagitis and gastritis |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147449 For inhibition of vascularization and for cancer therapy |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146967 Novel g protein-coupled receptor protein and dna thereof |
| 07/29/2004 | US20040146923 for treatment of tendinitis and tendon or ligament defects and in related tissue repair, wound healing, and augmenting bone morphogenetic protein (bmp) activity |
| 07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 07/29/2004 | US20040146856 Viral vector coding antiproliferative agent for treatment of tumors; antitumor agents and artificial chromosome gene therapy |
| 07/29/2004 | US20040146594 Therapy for dental hypersensitivity |
| 07/29/2004 | US20040146508 Use of cd25 binding molecules in steroid-resistant patients |
| 07/29/2004 | US20040146504 Anti-IgE vaccines |
| 07/29/2004 | US20040146493 Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 07/29/2004 | DE10301981A1 Use of combination of cinnarizin and dimenhydrinate to treat dizziness e.g. caused by inner ear disorders or violent motion |
| 07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
| 07/29/2004 | CA2507008A1 Use of cc-chemokine mutants against liver diseases |
| 07/28/2004 | EP1440692A1 Medical adsorbent and process for production thereof |
| 07/28/2004 | EP1440076A1 Silicon compounds |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440071A1 Imidazopyridine compounds as 5-ht 4? receptor modulators |
| 07/28/2004 | EP1440070A1 4-(5-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440069A1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders |
| 07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439847A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| 07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
| 07/28/2004 | EP1439838A1 Macrolides containing pharmaceutical compositions |
| 07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 07/28/2004 | EP1439833A1 Combination of liponic acid and glutamine in food and pharmaceutical products |
| 07/28/2004 | EP1439826A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 07/28/2004 | EP1439819A1 Formulation of an erodible, gastic retentive oral dosage form using in vitro disintegration test data |
| 07/28/2004 | EP1322593B1 O-substituted 6-methyl-tramadol derivatives |
| 07/28/2004 | EP1322592B1 Substituted 1-aminobutan-3-ol derivatives |
| 07/28/2004 | EP1207894B1 Use of a synergistic composition for the manufacture of a medicament for the treatment of liver associated ailments |
| 07/28/2004 | EP1171003B1 Complete feed for fish larvae and method for preparing same |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0831821B1 Optically pure (-) norcisapride for treating digestive tract disorders |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516699A Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516599A Method for joint treatment of chronic hepatitis C infection using ribavirin-polyvinyl glycol interferon alpha |
| 07/28/2004 | CN1516590A 4'-substituted nucleosides |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1515580A Two (2)-4-hydroxycinnamic acid glycosides and their application |
| 07/28/2004 | CN1515579A Fatty alcohol glycoside compound-acanthus ilicifolius glycoside C and its application |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515314A Human liver regeneration related protein and its application |
| 07/28/2004 | CN1515313A Guibiegongjiang capsule and its preparation method |
| 07/28/2004 | CN1515310A Turmeria oil extract dripping pill, its preparation method and application |
| 07/28/2004 | CN1515308A Chinese patent medicine for curing chronix virus B hepatitis and its preparation method |
| 07/28/2004 | CN1515302A Chinese medicine granule preparation for curing stomatocace |
| 07/28/2004 | CN1515298A Preparation method of pentaester granules |
| 07/28/2004 | CN1515295A Astragalus root extract injection and its preparation method |
| 07/28/2004 | CN1515292A Tenderizing and detoxicating health-care cold tea and its preparation method |
| 07/28/2004 | CN1515282A Chinese medicine powder for radically curing gastropathy-weibing Genzhi san and its preparation method |
| 07/28/2004 | CN1515281A Medicine for curing gastropathy |
| 07/28/2004 | CN1515267A Health plaster with the functions of promoting blood circulation and discharging toxicity |
| 07/28/2004 | CN1515265A Application of Chinese medicine polysaccharide as colonic drug-transferring carrier |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515255A Tannic acid berberine lozenge, its preparation method and application |
| 07/28/2004 | CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159312C Novel poyrimidine derivatives and process for preparation thereof |
| 07/28/2004 | CN1159311C Dihydropyrimidines |